Selective Inhibition of Acyl-CoA:cholesterol Acyltransferase 2 Isozyme by Flavasperone and Sterigmatocystin from Aspergillus Species

Five known fungal metabolites, aurasperone A, aurasperone D, averufanin, flavasperone and sterigmatocystin, were isolated from the culture broths of Aspergillus species as inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT) in the cell-based assay using ACAT1- and ACAT2-expressing CHO cells. These compounds share a similar polycyclic skeleton. Among them, flavasperone and sterigmatocystin, having an angular skeleton, showed selective inhibition toward ACAT2 isozyme, while the others having a linear one had no selectivity in inhibition.

[1]  T. Tsuchiya,et al.  Phenolic constituents of Cassia seeds and antibacterial effect of some naphthalenes and anthraquinones on methicillin-resistant Staphylococcus aureus. , 1999, Chemical & pharmaceutical bulletin.

[2]  K. Cadigan,et al.  Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. , 1993, The Journal of biological chemistry.

[3]  Mats Eriksson,et al.  ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver , 2004, Circulation.

[4]  A. Barison,et al.  Complete 1H and 13C NMR assignments of aurasperone A and fonsecinone A, two bis‐naphthopyrones produced by Aspergillus aculeatus , 2005, Magnetic resonance in chemistry : MRC.

[5]  Y. Hatsuda,et al.  Studies on the Metabolic Products of Aspergillus versicolor , 1954 .

[6]  Hideyuki Kobayashi,et al.  A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. , 2007, Atherosclerosis.

[7]  Hiroshi Tanaka,et al.  Yellow Pigments of Aspergillus niger and Asp. awamori , 1966 .

[8]  V. D. Piaz,et al.  Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs. , 2003, Mini reviews in medicinal chemistry.

[9]  M. Alegret,et al.  Acyl coenzyme A:cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs. , 2004, Methods and findings in experimental and clinical pharmacology.

[10]  Robert L. Hamilton,et al.  Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice , 2000, Nature Medicine.

[11]  J. R. Hanson,et al.  The Chemistry of Fungi , 2008 .

[12]  C. Rabie,et al.  Structural elucidation of the nigerones, four new naphthopyrones from cultures of Aspergillus niger , 1981 .

[13]  B. R. Krause,et al.  ACAT-2, A Second Mammalian Acyl-CoA:Cholesterol Acyltransferase , 1998, The Journal of Biological Chemistry.

[14]  S. Ōmura,et al.  Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. , 2007, Pharmacology & therapeutics.

[15]  S. Ghosal,et al.  Toxic naphtho-gamma-pyrones from Aspergillus niger. , 1979, Journal of agricultural and food chemistry.

[16]  K. Pachler,et al.  Carbon-13 nuclear magnetic resonance assignments and biosynthesis of aflatoxin B1 and sterigmatocystin. , 1976, Journal of the Chemical Society. Perkin transactions 1.

[17]  R. Mateles,et al.  Isolation of averufin from a mutant of Aspergillus parasiticus impaired in aflatoxin biosynthesis. , 1972, Biochemical and biophysical research communications.

[18]  S. Ōmura,et al.  Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A* , 2008, Journal of Biological Chemistry.

[19]  Hiroshi Tomoda,et al.  Selectivity of Microbial Acyl-CoA : cholesterol Acyltransferase Inhibitors toward Isozymes , 2007, The Journal of Antibiotics.

[20]  Robert V Farese,et al.  Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. S. Shelness,et al.  Identification of a Form of Acyl-CoA:Cholesterol Acyltransferase Specific to Liver and Intestine in Nonhuman Primates* , 1998, The Journal of Biological Chemistry.

[22]  S. Perrey,et al.  Absence of ACAT-1 Attenuates Atherosclerosis but Causes Dry Eye and Cutaneous Xanthomatosis in Mice with Congenital Hyperlipidemia* , 2000, The Journal of Biological Chemistry.

[23]  C. Townsend,et al.  Ordering the reductive and cytochrome P450 oxidative steps in demethylsterigmatocystin formation yields general insights into the biosynthesis of aflatoxin and related fungal metabolites. , 2005, Journal of the American Chemical Society.

[24]  Hiroshi Tomoda,et al.  Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. , 2004, Journal of lipid research.

[25]  R. Tan,et al.  Endophytic naphthopyrone metabolites are co-inhibitors of xanthine oxidase, SW1116 cell and some microbial growths. , 2004, FEMS microbiology letters.

[26]  W. Whalley,et al.  494. The chemistry of fungi. Part XXI. Asperxanthone and a preliminary examination of aspergillin , 1953 .

[27]  B. Roth.  ACAT inhibitors : evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents , 1998 .

[28]  J. Billheimer,et al.  Characterization of Two Human Genes Encoding Acyl Coenzyme A:Cholesterol Acyltransferase-related Enzymes* , 1998, The Journal of Biological Chemistry.